Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Mintzer

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Lung Cancer (Amsterdam, Netherlands)|May 30, 2006
Administration of pemetrexed immediately following gemcitabine as front-line therapy in advanced non-small cell lung cancer: a phase II trialJoseph Treat, Philip Bonomi, Michael McCleod, et al.
Clinical Journal of Oncology Nursing|June 19, 2007
Treating one of our ownKim E Consalvo, Linda D Piscitelli, Lindsay Williamson, et al.
Lung Cancer (Amsterdam, Netherlands)|November 10, 2006
Single-arm, open label study of pemetrexed plus cisplatin in chemotherapy naïve patients with malignant pleural mesothelioma: outcomes of an expanded access programColeman K Obasaju, Zhishen Ye, Antoinette J Wozniak, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Pemetrexed alone or in combination with cisplatin in previously treated malignant pleural mesothelioma: outcomes from a phase IIIB expanded access programPasi A Jänne, Antoinette J Wozniak, Chandra P Belani, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 2, 2008
Promising survival in patients with recurrent non-small cell lung cancer treated with docetaxel and gemcitabine in combination as second-line therapyChao Hui Huang, Michael M Millenson, Eric J Sherman, et al.
Clinical Lung Cancer|August 16, 2005
Open-label study of pemetrexed alone or in combination with cisplatin for the treatment of patients with peritoneal mesothelioma: outcomes of an expanded access programPasi A Jänne, Anoinette J Wozniak, Chandra P Belani, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Lung Cancer (Amsterdam, Netherlands)|May 30, 2006
Administration of pemetrexed immediately following gemcitabine as front-line therapy in advanced non-small cell lung cancer: a phase II trialJoseph Treat, Philip Bonomi, Michael McCleod, et al.
Clinical Journal of Oncology Nursing|June 19, 2007
Treating one of our ownKim E Consalvo, Linda D Piscitelli, Lindsay Williamson, et al.
Lung Cancer (Amsterdam, Netherlands)|November 10, 2006
Single-arm, open label study of pemetrexed plus cisplatin in chemotherapy naïve patients with malignant pleural mesothelioma: outcomes of an expanded access programColeman K Obasaju, Zhishen Ye, Antoinette J Wozniak, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Pemetrexed alone or in combination with cisplatin in previously treated malignant pleural mesothelioma: outcomes from a phase IIIB expanded access programPasi A Jänne, Antoinette J Wozniak, Chandra P Belani, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 2, 2008
Promising survival in patients with recurrent non-small cell lung cancer treated with docetaxel and gemcitabine in combination as second-line therapyChao Hui Huang, Michael M Millenson, Eric J Sherman, et al.
Clinical Lung Cancer|August 16, 2005
Open-label study of pemetrexed alone or in combination with cisplatin for the treatment of patients with peritoneal mesothelioma: outcomes of an expanded access programPasi A Jänne, Anoinette J Wozniak, Chandra P Belani, et al.
Pageof 2